Start with one model. Add the rest when you need them.
Subscriptions for clinical teams, metered APIs for builders and study licences for pharma.
Sandbox
Researchers and developers exploring the API.
- 500 predictions a month
- Synthetic and de-identified data only
- Immunotherapy model
- Community support
Clinic
A single oncology service or private clinic.
- 5,000 predictions a month
- 10 clinician seats
- Patient summary PDFs
- Add ADC or bispecific models
- Email support
Hospital
Cancer centres and hospital groups.
- 20,000 predictions a month
- Unlimited clinician seats
- SMART on FHIR EHR launch
- SSO, audit log, 99.9% SLA
- Named clinical success lead
Pharma & Enterprise
Sponsors, CROs and health systems.
- Per-study or enterprise licence
- All four models plus early access
- Private VPC or on-prem
- Co-development and fine-tuning
- GxP-ready audit logging
Pay per prediction.
For builders and pilots. Volume pricing starts at 50,000 calls a month.
Questions
Is Cure-IO a medical device?
Cure-IO is clinical decision support. It informs a conversation and does not diagnose or decide treatment. Regulatory status varies by region and model, and each model card states its current intended use.
Can we license only one model?
Yes. Every plan lets you choose which therapy-class models to enable, and you can add more from the licensing portal at any time.
How do pharma study licences work?
Study licences are priced per programme and cover the indications, sites and duration you need, with optional private deployment and co-development terms.
Where is patient data processed?
In the region you choose (UK, EU or US). Inputs are de-identified, encrypted in transit and at rest, and are not used for training without a separate written agreement.
Bring explainable immunotherapy predictions to your team.
Book a 30-minute walkthrough for your clinical, data or pharma team, or start free in the Sandbox.